EUCTR2012-003559-13-PT进行中（未招募）不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD). International, multicenter, double-blind, randomized, parallel group study
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 952
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patient 20 to 75 years old (inclusive),
- •Male or female,
- •Outpatients,
- •Patients suffering from primary chronic venous disease
- •Clinical class C0s to C4s on the most affected leg, according to the CEAP classification,
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 852
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •Pregnancy, breastfeeding or possibility of becoming pregnant during the study
研究者
相似试验
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).Patients suffering from symptomatic Chronic Venous Disease (CVD).MedDRA version: 14.1Level: LLTClassification code 10066682Term: Chronic venous insufficiencySystem Organ Class: 100000004866EUCTR2012-003559-13-ESInstitut de Recherches Internationales Servier952
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).EUCTR2012-003559-13-CZInstitut de Recherches Internationales Servier952
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).EUCTR2012-003559-13-SIInstitut de Recherches Internationales Servier952
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).Patients suffering from symptomatic Chronic Venous Disease (CVD).MedDRA version: 16.1Level: LLTClassification code 10066682Term: Chronic venous insufficiencySystem Organ Class: 100000004866EUCTR2012-003559-13-SKInstitut de Recherches Internationales Servier952
招募中
不适用
Comparisons of different filling materials in Non carious cervical Lesion .CTRI/2021/08/035494Dr Tanu300